Table 1: The factors analysed in this study.
Variable |
Value |
n = 518 |
Variable |
Value |
n = 518 |
Age (years) |
6-88 |
(med.53) |
Sex (man) |
343 |
(66.2%) |
preoperative sBP (mmHg) |
79-179 |
(med.122) |
Hypertension (yes) |
126 |
(24.3%) |
preoperative dBP (mmHg) |
32-116 |
(med.74) |
Asthma (yes) |
122 |
(23.5%) |
Number of inflamed sinuses (pieces) |
0-10 |
(med.6) |
Antithrombotic medication (yes) |
23 |
(4.4%) |
Lund-Mackay score (points) |
0-24 |
(med.8) |
Smoking habit (yes) |
261 |
(50.9%) |
Operative time (minutes) |
20-349 |
(med.154) |
Alcohol consumption (yes) |
282 |
(54.3%) |
Number of sinuses opened (pieces) |
1.-10 |
(med.8) |
Sinus disease |
||
WBC (/μl) |
2600-12830 |
(med.6005) |
Odontogenic maxillary sinusitis |
61 |
(11.8%) |
Neu/Lym ratio |
0.64-19.4 |
(med.1.82) |
Fungal sinusitis |
53 |
(10.2%) |
Eos (%) |
0.1-59.1 |
(med.3.65) |
Eosinophilic chronic rhinosinuitis |
65 |
(12.5%) |
Hb (g/dl) |
9.3-17.8 |
(med.14.3) |
Cystic disease |
24 |
(4.6%) |
Plt (10^4/μl) |
10.1-50.1 |
(med.23.6) |
CRS with/without nasal polyps |
315 |
(60.7%) |
Alb (g/dl) |
2.8-5.6 |
(med.4.5) |
Nasal polyps (yes) |
309 |
(59.5%) |
AST (U/L) |
9-164 |
(med.22) |
Preoperative macrolide dose (yes) |
162 |
(31.2%) |
ALT (U/L) |
6-169 |
(med.19) |
Preoperative steroid dose (yes) |
63 |
(12.1%) |
γ-GTP (U/L) |
8-213 |
(med.25) |
Initial surgery or re-operation (Initial) |
428 |
(82.6%) |
ALP (U/L) |
96-1837 |
(med.218) |
Unilateral or bilateral (bilateral) |
313 |
(60.4%) |
T-bil (mg/dl) |
0.3-2.7 |
(med.0.7) |
|||
Creatinine (mg/dl) |
0.34-12.61 |
(med.0.75) |
|||
CRP (mg/dl) |
0.001-11.319 |
(med.0.104) |
|||
PT-INR |
0.81-3.97 |
(med.0.97) |
|||
APTT (seconds) |
13.7-72 |
(med.30.3) |
WBC: White Blood Cell; Neu/Lym ratio: Neutrophil/Lymphocyte; Eos: Eosinophils; Hb: Haemoglobin; Plt: Platelet; Alb: Albumin; AST: Aspartate Aminotransferase; ALT: Alanine Aminotransferase; γ-GTP: γ-Glutamyl Transpeptidase; ALP: Alkaline Phosphatase; T-bil: Total Bilirubin; CRP: C-Reactive Protein; PT-INR: Prothrombin Time-International Normalised Ratio; APTT: Activated Partial Thromboplastin Time; CRS: Chronic Rhinosinusitis